株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界のポイントオブケア検査(POCT)市場

Global Point-of-Care Testing (POCT) Market

発行 Frost & Sullivan 商品コード 273586
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
世界のポイントオブケア検査(POCT)市場 Global Point-of-Care Testing (POCT) Market
出版日: 2013年05月31日 ページ情報: 英文
概要

当レポートでは、世界のポイントオブケア検査(POCT)市場について調査分析し、市場全体/セグメント別の概要、市場エンジニアリング評価、収益予測、競合分析、主要動向について検証し、地域別の市場分析も含めて、概略以下の構成でお届けいたします。

本調査で扱っている内容

  • 現在のPOCT市場のシナリオは?
  • 主な市場促進要因、克服すべき障壁は?
  • 主な市場セグメントは?重要な動向は?
  • 市場参入の主要企業は?
  • 地域別の政策・償還システムの変化は?将来どのような影響を市場に与えるか?
  • POCT市場の将来は?成功要因は?

第1章 エグゼクティブサマリー

第2章 市場の概要とセグメンテーション

第3章 POCT:総合市場

  • 外部の課題:促進要因・抑制要因
  • 予測と動向
  • PEST分析
  • 市場シェアと競合分析

第4章 セグメント分析

  • POCTセグメント基準分析

第5章 地域分析

第6章 米国

  • 市場エンジニアリング評価
  • 収益予測
  • 市場シェア
  • 競合環境
  • 競合分析
  • 潜在的な市場機会

第7章 米国の血糖POCT市場

  • 市場エンジニアリング評価
  • 収益予測
  • 主要動向
  • 市場シェア
  • 競合環境

第8章 米国のグリコヘモグロビン(HbA1c)POCT市場

第9章 米国のコレステロールPOCT市場

第10章 米国の血液ガス・電解質POCT市場

第11章 米国の薬物乱用POCT市場

第12章 米国の感染症POCT市場

第13章 米国の妊娠POCT市場

第14章 米国の血液POCT市場

第15章 米国の活性化凝固時間(ACT)/活性化部分トロンボプラスチン時間(APTT)検査POCT市場

第16章 米国の凝固プロトロンビン時間(PT)POCT市場

第17章 米国の心臓バイオマーカーPOCT市場

第18章 米国の便潜血POCT市場

第19章 米国の尿検査POCT市場

第20章 西欧

  • 市場エンジニアリング評価
  • 収益予測
  • 市場シェア
  • 競合環境
  • 競合分析
  • 潜在的な市場機会

第21章 西欧の血糖POCT市場

  • 市場エンジニアリング評価
  • 収益予測
  • 主要動向
  • 市場シェア
  • 競合環境

第22章 西欧のグリコヘモグロビン(HbA1c)POCT市場

第23章 西欧のコレステロールPOCT市場

第24章 西欧の血液ガス・電解質POCT市場

第25章 西欧の薬物乱用POCT市場

第26章 西欧の感染症POCT市場

第27章 西欧の妊娠POCT市場

第28章 西欧の血液POCT市場

第29章 西欧の迅速凝固POCT市場

第30章 西欧の心臓バイオマーカーPOCT市場

第31章 西欧の便潜血POCT市場

第32章 西欧の尿検査POCT市場

第33章 英国

  • 市場エンジニアリング評価
  • 収益予測

第34章 ドイツ

  • 市場エンジニアリング評価
  • 収益予測

第35章 フランス

  • 市場エンジニアリング評価
  • 収益予測

第36章 イタリア

  • 市場エンジニアリング評価
  • 収益予測

第37章 スペイン

  • 市場エンジニアリング評価
  • 収益予測

第38章 ベネルクス

  • 市場エンジニアリング評価
  • 収益予測

第39章 スカンジナビア

  • 市場エンジニアリング評価
  • 収益予測

第40章 その他の地域

第41章 戦略的提言

第42章 まとめ

第44章 付録

目次
Product Code: M8FD-01-00-00-00

Abstract

Increasing Adoption of POCT in Emerging Countries will Provide Impetus to Market Growth

Reduced turnaround time and potential benefits of immediate diagnosis have resulted in an increased adoption of POCT in hospitals and physician office laboratories. However, whether POC tests replace traditional laboratory tests is a question still being debated in the scientific community. This study provides the market overview, market engineering measurements, revenue forecasts, competitive analysis and key trends for the POCT market and its segments. Regional analysis includes the United States, Western European countries such as the United Kingdom, Germany, France, Italy, Spain, Benelux, and Scandinavia. The Rest of World regions have also been covered. The period covered in the study is 2009-2019, with 2012 as the base year.

Key Questions This Study Will Answer

  • What is the current POCT market scenario?
  • What are the key factors driving the market and the barriers that need to be overcome?
  • Which are the major market segments, and what are the important trends?
  • Which are the key market participants involved?
  • What are the key changes in the policy and reimbursement systems of the different regions, and how will they impact the POCT market in the future?
  • What is the future of the POCT market, and what should market participants do to succeed?

Table of Contents

  • 1. Executive Summary
  • 2. Market Overview and Segmentation
  • 3. Total POCT Market
    • External Challenges: Drivers and Restraints
    • Forecasts and Trends
    • PEST Analysis
    • Market Share and Competitive Analysis
  • 4. Segment Analysis
    • POCT Segment Metrics Analysis
  • 5. Regional Analysis
  • 6. US Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
    • Market Share
    • Competitive Environment
    • Competitive Analysis
    • Snapshot of Potential Opportunities-US
  • 7. US Blood Glucose POCT Segment Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
    • Key Trends
    • Market Share
    • Competitive Environment
  • 8. US HbA1C POCT Segment Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
    • Key Trends
    • Market Share
    • Competitive Environment
  • 9. US Cholesterol POCT Segment Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
    • Key Trends
    • Market Share
    • Competitive Environment
  • 10. US Blood Gas and Electrolyte POCT Segment Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
    • Key Trends
    • Market Share
    • Competitive Environment
  • 11. US Drugs-of-Abuse POCT Segment Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
    • Key Trends
    • Market Share
    • Competitive Environment
  • 12. US Infectious Disease POCT Segment Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
    • Key Trends
    • Market Share
    • Competitive Environment
  • 13. US Pregnancy POCT Segment Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
    • Key Trends
    • Market Share
    • Competitive Environment
  • 14. US Haematology POCT Segment Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
    • Key Trends
    • Market Share
    • Competitive Environment
  • 15. US Coagulation Active Clotting Time (ACT)/Activated Partial Thromboplastin Time (APTT) testing POCT Segment Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
    • Key Trends
    • Market Share
    • Competitive Environment
  • 16. US Coagulation Prothrombin Time (PT) POCT Segment Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
    • Key Trends
    • Market Share
    • Competitive Environment
  • 17. US Cardiac Biomarkers POCT Segment Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
    • Key Trends
    • Market Share
    • Competitive Environment
  • 18. US Fecal Occult POCT Segment Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
    • Key Trends
    • Market Share
    • Competitive Environment
  • 19. US Urinalysis POCT Segment Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
    • Key Trends
    • Market Share
    • Competitive Environment
  • 20. Western Europe Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
    • Market Share
    • Competitive Environment
    • Competitive Analysis
    • Snapshot of Potential Opportunities-Western Europe
  • 21. Western Europe Blood Glucose POCT Segment Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
    • Key Trends
    • Market Share
    • Competitive Environment
  • 22. Western Europe HbA1C POCT Segment Breakdown
  • 23. Market Engineering Measurements
    • Revenue Forecast
    • Key Trends
    • Market Share
    • Competitive Environment
  • 24. Western Europe Cholesterol POCT Segment Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
    • Key Trends
    • Market Share
    • Competitive Environment
  • 25. Western Europe Blood Gas and Electrolyte POCT Segment Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
    • Key Trends
    • Market Share
    • Competitive Environment
  • 26. Western Europe Drugs-of-Abuse POCT Segment Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
    • Key Trends
    • Market Share
    • Competitive Environment
  • 27. Western Europe Infectious Disease POCT Segment Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
    • Key Trends
    • Market Share
    • Competitive Environment
  • 28. Western Europe Pregnancy POCT Segment Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
    • Key Trends
    • Market Share
    • Competitive Environment
  • 29. Western Europe Haematology POCT Segment Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
    • Key Trends
    • Market Share
    • Competitive Environment
  • 30. Western Europe Rapid Coagulation POCT Segment Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
    • Key Trends
    • Market Share
    • Competitive Environment
  • 31. Western Europe Cardiac Biomarkers POCT Segment Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
    • Key Trends
    • Market Share
    • Competitive Environment
  • 32. Western Europe Fecal Occult POCT Segment Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
    • Key Trends
    • Market Share
    • Competitive Environment
  • 33. Western Europe Urinalysis POCT Segment Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
    • Key Trends
    • Market Share
    • Competitive Environment
  • 34. UK Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
  • 35. Germany Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
  • 36. France Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
  • 37. Italy Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
  • 38. Spain Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
  • 39. Benelux Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
  • 40. Scandinavia Breakdown
    • Market Engineering Measurements
    • Revenue Forecast
  • 41. Rest of World Breakdown
    • China
    • India
    • Central and Eastern Europe
    • Australia
    • Japan
    • Taiwan
    • South Korea and Rest of World
    • Rest of World Market-Market Engineering Measurements
    • Rest of World Market-Revenue Forecast
    • Snapshot of Potential Opportunities-Rest of World
  • 42. Strategic Recommendations
  • 43. The Last Word (Conclusions and Implications)
  • 44. Appendix

List of Exhibits

  • Total POCT Market: Market Segmentation, Global, 2012
  • Total POCT Market: Geographic Segmentation, Global, 2012
  • Total POCT Market: Market Engineering Measurements, Global, 2012
  • Total POCT Market: Per cent of Sales, Global, 2012
  • POCT Market: Key Market Drivers and Restraints, US and Western Europe, 2013-2019
  • Total POCT Market: Turnaround Time of Selected Key Tests, Global, 2012
  • Total POCT Market: Cost Analysis of Key Tests, Global, 2012
  • POCT Market: Impact Mapping of Drivers and Restraints, US and Western Europe, 2013-2019
  • POCT Market: Key Market Drivers and Restraints, Rest of World, 2013-2019
  • POCT Market: Impact Mapping of Drivers and Restraints, Rest of World, 2013-2019
  • Total POCT Market: Market Engineering Measurements, Global, 2012
  • Total POCT Market: Revenue Forecast, Global, 2009-2019
  • POCT Market: PEST Analysis, US and Western Europe, 2012
  • POCT Market: PEST Analysis, Rest of World, 2012
  • Total POCT Market: Per cent of Sales, Global, 2012
  • Total POCT Market: Company Market Share Analysis of Top 5 Participants, Global, 2012
  • Total POCT Market: Selected Key Participants, Global, 2012
  • Total POCT Market: Competitive Structure, Global, 2012
  • POCT Market: Metrics Analysis, US and Western Europe, 2012
  • Total POCT Market: Per cent of Sales by Region, Global, 2012
  • POCT Market: Market Engineering Measurements, US, 2012
  • POCT Market: Revenue Forecast, US, 2009-2019
  • POCT Market: Per cent of Sales, US, 2012
  • POCT Market: Company Market Share Analysis of Top 4 Participants, US, 2012
  • POCT Market: Competitive Structure, US, 2012
  • POCT Market: Ranking of Key Participants Based on Market Share, US, 2012
  • POCT Market: Snapshot of Potential Opportunities, US, 2012-20194
  • Blood Glucose POCT Segment: Market Engineering Measurements, US, 20126
  • Blood Glucose POCT Segment: Revenue Forecast, US, 2009-2019
  • Blood Glucose POCT Segment: Impact Assessment of Key Trends, US, 2012
  • Blood Glucose POCT Segment: Per cent of Sales, US , 2012
  • Blood Glucose POCT Segment: Company Market Share Analysis of Top 5 Participants, US, 2012
  • Blood Glucose POCT Segment: Competitive Structure, US, 2012
  • HbA1C POCT Segment: Market Engineering Measurements, US 2012
  • HbA1C POCT Segment: Revenue Forecast, US, 2009-2019
  • HbA1C POCT Segment: Impact Assessment of Key Trends, US, 2012
  • HbA1C POCT Segment: Per cent of Sales, US, 2012
  • HbA1C POCT Segment: Company Market Share Analysis of Top 4 Participants, US, 2012
  • HbA1C POCT Segment: Competitive Structure, US, 2012
  • Cholesterol POCT Segment: Market Engineering Measurements, US, 2012
  • Cholesterol POCT Segment: Revenue Forecast, US, 2009-2019
  • Cholesterol POCT Segment: Impact Assessment of Key Trends, US, 2012
  • Cholesterol POCT Segment: Per cent of Sales, US, 2012
  • Cholesterol POCT Segment: Company Market Share Analysis of Top 3 Participants, US, 2012
  • Cholesterol POCT Segment: Competitive Structure, US, 2012
  • Blood Gas and Electrolyte POCT Segment: Market Engineering Measurements, US, 2012
  • Blood Gas and Electrolyte POCT Segment: Revenue Forecast, US, 2009-2019
  • Blood Gas and Electrolyte POCT Segment: Impact Assessment of Key Trends, US, 2012
  • Blood Gas and Electrolyte POCT Segment: Per cent of Sales, US, 2012
  • Blood Gas and Electrolyte POCT Segment: Company Market Share Analysis of Top 4 Participants, US, 2012
  • Blood Gas and Electrolyte POCT Segment: Competitive Structure, US, 2012
  • Drugs-of-Abuse POCT Segment: Market Engineering Measurements, US, 2012
  • Drugs-of-Abuse POCT Segment: Revenue Forecast, US, 2009-2019
  • Drugs-of-Abuse POCT Segment: Impact Assessment of Key Trends, US, 2012
  • Drugs-of-Abuse POCT Segment: Per cent of Sales, US, 2012
  • Drugs-of-Abuse POCT Segment: Company Market Share Analysis of Top 2 Participants, US, 2012
  • Drugs-of-Abuse POCT Segment: Competitive Structure, US, 2012
  • Infectious Disease POCT Segment: Market Engineering Measurements, US, 2012
  • Infectious Disease POCT Segment: Revenue Forecast, United States, 2009-2019
  • Infectious Disease POCT Segment: Impact Assessment of Key Trends, US, 2012
  • Infectious Disease POCT Segment: Per cent of Sales, US, 2012
  • Infectious Disease POCT Segment: Company Market Share Analysis of Top 4 Participants, US, 2012
  • Infectious Disease POCT Segment: Competitive Structure, US, 2012
  • Pregnancy POCT Segment: Market Engineering Measurements, US, 2012
  • Pregnancy POCT Segment: Revenue Forecast, US, 2009-2019
  • Pregnancy POCT Segment: Impact Assessment of Key Trends, US, 2012
  • Pregnancy POCT Segment: Per cent of Sales, US, 2012
  • Pregnancy POCT Segment: Company Market Share Analysis of Top 3 Participants, US, 2012
  • Pregnancy POCT Segment: Competitive Structure, US, 2012
  • Haematology POCT Segment: Market Engineering Measurements, US, 2012
  • Haematology POCT Segment: Revenue Forecast, US, 2009-2019
  • Haematology POCT Segment: Impact Assessment of Key Trends, US, 2012
  • Haematology POCT Segment: Per cent of Sales, US, 2012
  • Haematology POCT Segment: Company Market Share Analysis of Top 4 Participants, US, 2012
  • Haematology POCT Segment: Competitive Structure, US, 2012
  • Coagulation ACT/APTT POCT Segment: Market Engineering Measurements, US, 2012
  • Coagulation ACT/APTT POCT Segment: Revenue Forecast, US, 2009-2019
  • Coagulation ACT/APTT POCT Segment: Impact Assessment of Key Trends, US, 2012
  • Coagulation ACT/APTT POCT Segment: Competitive Structure, US, 2012
  • Coagulation PT POCT Segment: Market Engineering Measurements, US, 2012
  • Coagulation PT POCT Segment: Revenue Forecast, US, 2009-2019
  • Coagulation PT POCT Segment: Impact Assessment of Key Trends, US, 2012
  • Coagulation PT POCT Segment: Per cent of Sales, US, 2012
  • Coagulation PT POCT Segment: Company Market Share Analysis of Top 4 Participants, US, 2012
  • Coagulation PT POCT Segment: Competitive Structure, US, 2012
  • Cardiac Biomarkers POCT Segment: Market Engineering Measurements, US, 2012
  • Cardiac Biomarkers POCT Segment: Revenue Forecast, US, 2009-2019
  • Cardiac Biomarkers POCT Segment: Impact Assessment of Key Trends, US, 2012
  • Cardiac Biomarkers POCT Segment: Per cent of Sales, US, 2012
  • Cardiac Biomarkers POCT Segment: Company Market Share Analysis of Top 4 Participants, US, 2012
  • Cardiac Biomarkers POCT Segment: Competitive Structure, US, 2012
  • Fecal Occult POCT Segment: Market Engineering Measurements, US, 2012
  • Fecal Occult POCT Segment: Revenue Forecast, US, 2009-2019
  • Fecal Occult POCT Segment: Impact Assessment of Key Trends, US, 2012
  • Fecal Occult POCT Segment: Per cent of Sales, US, 2012
  • Fecal Occult POCT Segment: Company Market Share Analysis of Top 3 Participants, US, 2012
  • Fecal Occult POCT Segment: Competitive Structure, US, 2012
  • Urinalysis POCT Segment: Market Engineering Measurements, US, 2012
  • Urinalysis POCT Segment: Revenue Forecast, US, 2009-2019
  • Urinalysis POCT Segment: Impact Assessment of Key Trends, US, 2012
  • Urinalysis POCT Segment: Per cent of Sales, US, 2012
  • Urinalysis POCT Segment: Company Market Share Analysis of Top 3 Participants, US, 2012
  • Urinalysis POCT Segment: Competitive Structure, US, 2012
  • POCT Market: Benefits and Challenges, Western Europe, 2012
  • POCT Market: Market Engineering Measurements, Western Europe, 2012
  • POCT Market: Revenue Forecast, Western Europe, 2009-2019
  • POCT Market: Per cent of Sales, Western Europe, 2012
  • POCT Market: Company Market Share Analysis of Top 5 Participants Western Europe, 2012
  • POCT Market: Competitive Structure, Western Europe, 2012
  • POCT Market: Ranking of Key Participants Based on Market Share, Western Europe, 2012
  • POCT Market: Snapshot of Potential Opportunities, Western Europe, 2012?2019
  • Blood Glucose POCT Segment: Market Engineering Measurements, Western Europe, 2012
  • Blood Glucose POCT Segment: Revenue Forecast, Western Europe, 2009-2019
  • Blood Glucose POCT Segment: Impact Assessment of Key Trends, Western Europe, 2012
  • Blood Glucose POCT Segment: Per cent of Sales, Western Europe, 2012
  • Blood Glucose POCT Segment: Company Market Share Analysis of Top 4 Participants, Western Europe, 2012
  • Blood Glucose POCT Segment: Competitive Structure, Western Europe, 2012
  • HbA1C POCT Segment: Market Engineering Measurements, Western Europe, 2012
  • HbA1C POCT Segment: Revenue Forecast, Western Europe, 2009-2019
  • HbA1C POCT Segment: Impact Assessment of Key Trends, Western Europe, 2012
  • HbA1C POCT Segment: Per cent of Sales, Western Europe, 2012
  • HbA1C POCT Segment: Company Market Share Analysis of Top 3 Participants, Western Europe, 2012
  • HbA1C POCT Segment: Competitive Structure, Western Europe, 2012
  • Cholesterol POCT Segment: Market Engineering Measurements, Western Europe, 2012
  • Cholesterol POCT Segment: Revenue Forecast, Western Europe, 2009-2019
  • Cholesterol POCT Segment: Impact Assessment of Key Trends, Western Europe, 2012
  • Cholesterol POCT Segment: Per cent of Sales, Western Europe, 2012
  • Cholesterol POCT Segment: Company Market Share Analysis of Top 3 Participants, Western Europe, 2012
  • Cholesterol POCT Segment: Competitive Structure, Western Europe, 2012
  • Blood Gas and Electrolyte POCT Segment: Market Engineering Measurements, Western Europe, 2012
  • Blood Gas and Electrolyte POCT Segment: Revenue Forecast, Western Europe, 2009-2019
  • Blood Gas and Electrolyte POCT Segment: Impact Assessment of Key Trends, Western Europe, 2012
  • Blood Gas and Electrolyte POCT Segment: Per cent of Sales, Western Europe, 2012
  • Blood Gas and Electrolyte POCT Segment: Company Market Share Analysis of Top 4 Participants, Western Europe, 2012
  • Blood Gas and Electrolyte POCT Segment: Competitive Structure, Western Europe, 2012
  • Drugs-of-Abuse POCT Segment: Market Engineering Measurements, Western Europe, 2012
  • Drugs-of-Abuse POCT Segment: Revenue Forecast, Western Europe, 2009-2019
  • Drugs-of-Abuse POCT Segment: Impact Assessment of Key Trends, Western Europe, 2012
  • Drugs-of-Abuse POCT Segment: Per cent of Sales, Western Europe, 2012
  • Drugs-of-Abuse POCT Segment: Company Market Share Analysis of Top 3 Participants, Western Europe, 2012
  • Drugs-of-Abuse POCT Segment: Competitive Structure, Western Europe, 2012
  • Infectious Disease POCT Segment: Market Engineering Measurements, Western Europe, 2012
  • Infectious Disease POCT Segment: Revenue Forecast, Western Europe, 2009-2019
  • Infectious Disease POCT Segment: Impact Assessment of Key Trends, Western Europe, 2012
  • Infectious Disease POCT Segment: Per cent of Sales, Western Europe, 2012
  • Infectious Disease POCT Segment: Company Market Share Analysis of Top 3 Participants, Western Europe, 2012
  • Infectious Disease POCT Segment: Competitive Structure, Western Europe, 2012
  • Pregnancy POCT Segment: Market Engineering Measurements, Western Europe, 2012
  • Pregnancy POCT Segment: Revenue Forecast, Western Europe, 2009-2019
  • Pregnancy POCT Segment: Impact Assessment of Key Trends, Western Europe, 2012
  • Pregnancy POCT Segment: Per cent of Sales, Western Europe, 2012
  • Pregnancy POCT Segment: Company Market Share Analysis of Top 3 Participants, Western Europe, 2012
  • Pregnancy POCT Segment: Competitive Structure, Western Europe, 2012
  • Haematology POCT Segment: Market Engineering Measurements, Western Europe, 2012
  • Haematology POCT Segment: Revenue Forecast, Western Europe, 2009-2019
  • Haematology POCT Segment: Impact Assessment of Key Trends, Western Europe, 2012
  • Haematology POCT Segment: Per cent of Sales, Western Europe, 2012
  • Haematology POCT Segment: Company Market Share Analysis of Top 4 Participants, Western Europe, 2012
  • Haematology POCT Segment: Competitive Structure, Western Europe, 2012
  • Rapid Coagulation POCT Segment: Market Engineering Measurements, Western Europe, 2012
  • Rapid Coagulation POCT Segment: Revenue Forecast, Western Europe, 2009-2019
  • Rapid Coagulation POCT Segment: Impact Assessment of Key Trends, Western Europe, 2012
  • Rapid Coagulation POCT Segment: Per cent of Sales, Western Europe, 2012
  • Rapid Coagulation POCT Segment: Company Market Share Analysis of Top 3 Participants, Western Europe, 2012
  • Rapid Coagulation POCT Segment: Competitive Structure, Western Europe, 2012
  • Cardiac Biomarkers POCT Segment: Market Engineering Measurements, Western Europe, 2012
  • Cardiac Biomarkers POCT Segment: Revenue Forecast, Western Europe, 2009-2019
  • Cardiac Biomarkers POCT Segment: Impact Assessment of Key Trends, Western Europe, 2012
  • Cardiac Biomarkers POCT Segment: Per cent of Sales, Western Europe, 2012
  • Cardiac Biomarkers POCT Segment: Company Market Share Analysis of Top 5 Participants, Western Europe, 2012
  • Cardiac Biomarkers POCT Segment: Competitive Structure, Western Europe, 2012
  • Fecal Occult POCT Segment: Market Engineering Measurements, Western Europe, 2012
  • Fecal Occult POCT Segment: Revenue Forecast, Western Europe, 2009-2019
  • Fecal Occult POCT Segment: Impact Assessment of Key Trends, Western Europe, 2012
  • Fecal Occult POCT Segment: Per cent of Sales, Western Europe, 2012
  • Fecal Occult POCT Segment: Company Market Share Analysis of Top 3 Participants, Western Europe, 2012
  • Fecal Occult POCT Segment: Competitive Structure, Western Europe, 2012
  • Urinalysis POCT Segment: Market Engineering Measurements, Western Europe, 2012
  • Urinalysis POCT Segment: Revenue Forecast, Western Europe, 2009-2019
  • Urinalysis POCT Segment: Impact Assessment of Key Trends, Western Europe, 2012
  • Urinalysis POCT Segment: Per cent of Sales, Western Europe, 2012
  • Urinalysis POCT Segment: Company Market Share Analysis of Top 3 Participants, Western Europe, 2012
  • Urinalysis POCT Segment: Competitive Structure, Western Europe, 2012
  • POCT Market: Market Engineering Measurements,UK, 2012
  • POCT Market: Revenue Forecast, UK, 2009-2019
  • POCT Market: Market Engineering Measurements, Germany, 2012
  • POCT Market: Revenue Forecast, Germany, 2009-2019
  • POCT Market: Market Engineering Measurements, France, 2012
  • POCT Market: Revenue Forecast, France, 2009-2019
  • POCT Market: Market Engineering Measurements, Italy, 2012
  • POCT Market: Revenue Forecast, Italy, 2009-2019
  • POCT Market: Market Engineering Measurements, Spain, 2012
  • POCT Market: Revenue Forecast, Spain, 2009-2019
  • POCT Market: Market Engineering Measurements, Benelux, 2012
  • POCT Market: Revenue Forecast, Benelux, 2009-2019
  • POCT Market: Market Engineering Measurements, Scandinavia, 2012
  • POCT Market: Revenue Forecast, Scandinavia, 2009-2019
  • POCT Market: Market Engineering Measurements, Rest of World, 2012
  • POCT Market: Revenue Forecast, Rest of World, 2009-2019
  • POCT Market: Snapshot Of Potential Opportunities, Rest of World, 2012-2019
  • Decision Support Database: Total Healthcare Expenditure, Global, 2008-2018
  • Decision Support Database: Public Healthcare Expenditure, Global, 2008-2018
  • Decision Support Database: Private Healthcare Expenditure, Global, 2008-2018
  • Decision Support Database: Number of Hospital Beds, Global, 2008-2018
  • Decision Support Database: Number of Hospitals, Global, 2008-2018
Back to Top